AI-enhanced algorithm improves diagnosis of REM sleep behavior disorder

A Mount Sinai-led team of researchers has enhanced an artificial intelligence (AI)-powered algorithm to analyze video recordings of clinical sleep tests, ultimately improving accurate diagnosis of a common sleep disorder affecting more than 80 million people worldwide.

FDA rejects Eli Lilly’s eczema drug due to third-party manufacturing issues

FDA has rejected Eli Lilly’s eczema treatment lebrikizumab due to issues found at an unnamed third-party manufacturer. According to a press release, a “multi-sponsor” inspection

October 3, 2023

Can ChatGPT revolutionize nutrition education? Study examines potential and challenges

The potential of ChatGPT application as a knowledge-enhancement tool in the nutrition domain.

October 25, 2023

Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation – Biotech Investments

Kinarus Therapeutics Holding AG / Key word(s): Acquisition/Capital Increase 29-Jan-2024 / 07:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.